InterventionsReview

Can obesity pharmacotherapy modify osteoarthritis? Interpreting pain relief, weight-loss quality, and structural outcomes

Figure 1 from Osteoarthritis and Cartilage — Figure 1Rombach et al.

Osteoarthritis and Cartilage

The paper

Rombach J, Hannani MT, Henriksen K et al.

Osteoarthritis and Cartilage · 21 Sep 2026

doi.org/10.1016/j.joca.2026.09.007 PubMed 42767324

Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026